Browse Related Topics For:

ANDA

153
Patents
114
Pharmaceutical
100
Generic Drugs
99
Patent Litigation
97
Pharmaceutical Patents
81
Patent Infringement
74
Pharmaceutical Manufacturers
58
FDA
57
Prescription Drugs
47
Hatch-Waxman
32
Reverse Payment Settlement Agreements
28
FTC
27
SCOTUS
26
FTC v Actavis
22
Biotechnology
19
Drug Manufacturers
19
Mylan Pharmaceuticals
17
Actavis Inc.
16
Teva Pharmaceuticals
15
Infringement
13
Obviousness
12
Apotex
12
Patent-in-Suit
11
Watson Pharmaceuticals
10
Antitrust Litigation
10
Pay-For-Delay
10
Pfizer
9
Cephalon
9
Claim Construction
9
FDCA
9
Merck
9
Prior Art
8
Jurisdiction
7
Appeals
7
Labeling
7
Novartis
7
Patent Invalidity
7
Personal Jurisdiction
7
Sandoz
6
AstraZeneca
6
Popular
6
Sherman Act
5
BPCIA
5
DaimlerAG
5
Motion to Dismiss
5
USPTO
4
Allergan Inc
4
Anti-Competitive
4
DaimlerChrysler v Bauman
4
Eli Lilly
4
Generic
4
GlaxoSmithKline
4
Healthcare
4
Induced Infringement
4
Manufacturers
4
Noninfringement
4
Orange Book
4
Orphan Drugs
4
Par Pharmaceutical
4
Patent Applications
4
Patent Trial and Appeal Board
4
Safe Harbors
4
Settlement
3
Amgen
3
Antitrust Provisions
3
Biologics
3
Biosimilars
3
Bristol-Myers Squibb
3
Classen Immunotherapies
3
Corporate Counsel
3
Declaratory Judgments
3
Elan Pharmaceuticals
3
Intellectual Property Litigation
3
Inter Partes Review Proceedings
3
Life Sciences
3
Medicare Modernization Act
3
Rule-of-Reason Analysis
3
Takeda Pharmaceuticals
3
Unfair Competition
3
Written Descriptions
2
AbbVie
2
America Invents Act
2
Antitrust Investigations
2
Biopharmaceutical
2
Cadence Pharmaceuticals Inc.
2
Certiorari
2
Chevron Deference
2
Citizen Petitions
2
Class Action
2
Disgorgement
2
Enablement Inquiries
2
Exclusivity
2
Extortion
2
Failure To Warn
2
FDA Approval
2
Federal Rule 12(b)(6)
2
Forum
2
Fresenius
2
Gilead Sciences
2
Indefiniteness
2
Inter Partes Reexamination
2
Malicious Prosecution
2
Medical Devices
2
Minimum Contacts
2
New Guidance
2
On-Sale Bar
2
Patent-Eligible Subject Matter
2
Pleadings
2
Preliminary Injunctions
2
Product Hopping
2
Prometheus
2
RanBaxy
2
Reversal
2
Reverse Payments
2
Subject Matter Jurisdiction
2
Summary Judgment
2
Trademarks
2
TRO
1
"lupin
1
Administrative Procedure Act
1
Advertising
1
Amarin
1
Amazon
1
Ambiguous
1
Anti-SLAPP
1
Antitrust Violations
1
Arbitration
1
Arbitration Agreements
1
Bausch & Lomb
1
Bayer
1
Bipolar Disorder
1
Boehringer
1
Brand
1
Burden of Proof
1
CA Supreme Court
1
Cal Code of Civil Procedure
1
Carve Out Provisions
1
Certifications
1
Cipro
1
Cisco v CommilUSA
1
Claim Preclusion
1
Claims Limitations Period
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
Combination Products
1
Competition
1
Complex Litigation
1
Compliance
1
Consent Order
1
Contract Drafting
1
Copyright
1
Counterclaims
1
Daiichi Sankyo
1
Damages
1
Disclosure
1
Disclosure Requirements
1
Dismissals
1
DSCSA
1
Duty to Deal
1
E-Filing
1
Exemptions
1
Expert Testimony
1
Expert Witness
1
Fair Market Value
1
FDA Warning Letters
1
FDASIA
1
Federal Jurisdiction
1
First Amendment
1
Foreign Corporations
1
Forest Laboratories
1
Genzyme
1
Good Faith
1
Goodyear
1
Government Investigations
1
HHS
1
Hoffman LaRoche
1
Information Reports
1
Injunctions
1
Innovation Act
1
Integra
1
International Arbitration
1
ITC
1
Janssen Pharmaceuticals
1
Jazz Pharmaceuticals
1
Judge Stark
1
Judgment on the Pleadings
1
Justiciable Controversy
1
Lanham Act
1
License Agreements
1
Licensing Rules
1
Lipitor
1
Manufacturing Facilities
1
Marketing
1
Means-Plus-Function
1
Medicare
1
Mensing
1
Misbranding
1
No-AG Agreement
1
Noerr-Pennington Doctrine
1
Non-Disclosure Agreement
1
Nunc Pro Tunc
1
Off-Label Promotion
1
Off-Label Use
1
Otsuka Pharmaceutical
1
Out-of-State Companies
1
OxyContin
1
PATENT Act
1
Patent Dance
1
Patent Prosecution
1
Patent Reform
1
Patent Term Extensions
1
Patients
1
Pharmacies
1
PLIVA v Mensing
1
Preemption
1
Presumption of Validity
1
Product Exclusivity
1
Product Labels
1
Proposed Legislation
1
Proposed Regulation
1
Public Meetings
1
Putative Class Actions
1
Real Party in Interest
1
Registration Requirement
1
Reissue Patents
1
Remand
1
REMS
1
Research Tools
1
Restraining Orders
1
Restrictive Covenants
1
Roxane Laboratories
1
Royalties
1
Rulemaking Process
1
Sales Contracts
1
Sanctions
1
Sandoz v Amgen
1
Set-Asides
1
SmithKline Beecham
1
SNDAs
1
Specific Jurisdiction
1
Spectrum
1
Split of Authority
1
Standard of Proof
1
Standards-Essential Patents
1
Standing
1
Startups
1
Subsidiaries
1
Trade Secrets
1
Transfer of Title
1
Vaccinations
1
Validity
1
Warner Chilcott
1
Warning Labels
1
WIPO
1
Wyeth